General transcription factor IIi pseudogene 12 (GTF2IP12)

General transcription factor IIi pseudogene 12 (GTF2IP12) is annotated as a pseudogene, not a functional protein-coding gene or established drug target. Pseudogenes are genomic DNA sequences similar to normal genes but typically nonfunctional due to mutations or lack of regulatory elements required for expression. GTF2IP12 appears in gene databases as a pseudogene related by sequence to members of the transcription factor IIi (GTF2I) family, which are involved in the regulation of gene expression. There are no known biological functions, disease associations, pharmacological roles, or clinical biomarkers documented for GTF2IP12. It is not an established or plausible therapeutic target. The functional gene GTF2I encodes a transcription factor involved in regulating transcription, cell cycle, and myelination, and has disease associations such as Williams syndrome, but GTF2IP12 specifically refers to a pseudogene and not to GTF2I. No evidence suggests GTF2IP12 is expressed or encodes a functional protein; consequently, it is not considered a valid biological or pharmacological target. The presence of "pseudogene" in its name is a strong indicator of lack of protein function and clinical relevance. If your query concerns the functional General transcription factor IIi (GTF2I) rather than the pseudogene, please specify, as that is a different entity with well-described gene/protein function and clinical relevance.

Other names

GTF2I pseudogene 12